Population‐based study on the seroprevalence of parvovirus B19 in Amsterdam
- 27 May 2009
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 81 (7), 1305-1309
- https://doi.org/10.1002/jmv.21528
Abstract
A study was undertaken to estimate the seroprevalence of parvovirus B19 infection in the general adult population of Amsterdam, The Netherlands. To our knowledge this is the first study testing parvovirus B19 in a random sample of the Dutch adult population. The study was a cross-sectional survey, and the study sample was stratified by age and ethnicity, with deliberate oversampling of minority ethnic groups. Serum samples obtained from 1,323 residents in 2004 were tested for antibodies to parvovirus B19. Basic demographic data (gender, age, country of birth, and number of children) were also available. Sixty-two percent of the participants were seropositive; corrected for the oversampling the estimated prevalence in the Amsterdam adult population was 61%. No specific predictors or risk groups for seropositivity were identified. In our urban adult study population no positive correlation with increasing neither age, nor significant differences between age groups were found. These results imply that almost 40% of the adult Amsterdam population is susceptible to infection. J. Med. Virol. 81:1305–1309, 2009.This publication has 16 references indexed in Scilit:
- Seroprevalence of parvovirus B19 in the German populationEpidemiology and Infection, 2008
- Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infectionEpidemiology and Infection, 2007
- Population‐based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004Journal of Medical Virology, 2007
- The burden of parvovirus B19 infection in women of childbearing age in England and WalesEpidemiology and Infection, 2007
- Prevalence and management of hypertension among Turkish, Moroccan and native Dutch ethnic groups in Amsterdam, the Netherlands: the Amsterdam Health Monitor SurveyJournal of Hypertension, 2006
- PARVOVIRUS B19 INFECTION IN PREGNANCYFetal and Maternal Medicine Review, 2005
- Human Parvovirus B19Clinical Microbiology Reviews, 2002
- Seronegativity to Varicella-Zoster Virus in a Tertiary Care Obstetric PopulationObstetrics & Gynecology, 1997
- Seroprevalence of Human Parvovirus B19 Infection in Sao Tomé and Principe, Malawi and Mascarene IslandsZentralblatt für Bakteriologie, 1989
- The prevalence of antibody to human parvovirus B 19 in England and WalesJournal of Medical Microbiology, 1988